PD-1 blockade plus cisplatin-based chemotherapy in patients with small cell/neuroendocrine bladder and prostate cancers

By sjmartinez • November 14, 2024

Gu Y, Ly A, Rodriguez S, Zhang H, Kim J, Mao Z, Sachdeva A, Zomorodian N, Pellegrini M, Li G, Liu S, Drakaki A, Rettig MB, Chin AI. PD-1 blockade plus cisplatin-based chemotherapy in patients with small cell/neuroendocrine bladder and prostate cancers. Cell Rep Med. 2024 Nov 6:101824. doi: 10.1016/j.xcrm.2024.101824. Epub ahead of print. PMID: 39536751.

Tags: Clinical Trial, Dermatology, Hematology/Oncology, immunochemotherapy, neuroendocrine prostate cancer, PD-1 blockade, Publications, single-cell sequencing, small cell bladder cancer, small cell cancers, T cell receptor sequencing, Veterans Administration

Patient-Identified Treatment Goals for Psoriatic Disease: Results From a US Patient Survey

Armstrong A, Levit NA, Schneider B, Seiden R, Shi L, Kaplan B, Wu JJ. Patient-Identified Treatment Goals for Psoriatic Disease: Results From a US Patient[...]

A genomic analysis reveals the diversity of cellulosome displaying bacteria

Minor CM, Takayesu A, Ha SM, Salwinski L, Sawaya MR, Pellegrini M, Clubb RT. A genomic analysis reveals the diversity of cellulosome displaying bacteria. Front[...]

Complete genome of Variovorax sp. EBFNA2, isolated from a surface-sterilized fava bean nodule

Hirsch AM, Humm E, Rubbi L, Del Vecchio G, Ha SM, Pellegrini M, Gunsalus RP. Complete genome of Variovorax sp. EBFNA2, isolated from a surface-sterilized fava bean[...]